Evidence map›Paper›PMID 12496186›Full record

ArticleInfection and immunity2003

Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa.

Tong-Jun Lin, Lauren H Maher, Kaede Gomi, Jeffrey D McCurdy, Rafael Garduno, Jean S Marshall

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in immunology · 2024
    Review
  4. Article
  5. Article
  6. The P2YCellular and molecular life sciences : CMLS · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Mast cells mediate Pseudomonas aeruginosa lipopolysaccharide-induced lung inflammation in rat.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
  15. Article
  16. Article
  17. Article
  18. Microarray-based analysis of ventilator-induced lung injury.Proceedings of the American Thoracic Society · 2007
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Tong-Jun LinDepartment of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, B3H 4H7 Canada.
Lauren H Maher
Kaede Gomi
Jeffrey D McCurdy
Rafael Garduno
Jean S Marshall
Dalhousie University · CAPediatrics and Genetics · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells are important as sentinel cells in host defense against bacterial infection. Much of their effectiveness depends upon recruiting other immune cells; however, little is known about the mechanisms of this response. CCL20, also known as macrophage inflammatory protein-3alpha (MIP-3alpha), Exodus, and LARC, is a chemokine known to be a potent chemoattractant for immature dendritic cells and T cells. In this study, we examined the human mast cell production of both CCL20 and granulocyte-macrophage colony-stimulating factor (GM-CSF), a critical cytokine for innate immune responses in the lung, in response to Pseudomonas aeruginosa. Reverse transcription-PCR and Western blot analysis demonstrated that the human mast cells (HMC-1) express CCL20 mRNA and are able to produce a significant amount (32.4 ng/ml) of CCL20 protein following stimulation by calcium ionophore and phorbol myristate acetate. Importantly, P. aeruginosa potently stimulated CCL20 production in human cord blood-derived mast cells (CBMC), with production peaking at 6 h after stimulation. This time course of expression was distinct from that of GM-CSF, which peaked after 24 to 48 h. Significant CCL20 production did not occur following immunoglobulin E-mediated activation of CBMC under conditions which induced a substantial GM-CSF response. Interestingly, the CCL20 response of mast cells to P. aeruginosa was relatively resistant to inhibition by the corticosteroid dexamethasone, interleukin-10, or cyclosporine, while GM-CSF production was potently inhibited. However, P. aeruginosa-induced CCL20 production was blocked by the protein kinase C (PKC) inhibitor Ro 31-8220 and a PKC pseudosubstrate. These results support a role for human mast cells in the initiation of immune responses to P. aeruginosa infection.

Indexed as

Receptors, ChemokineCell LineCells, CulturedChemokine CCL20Chemokines, CCCyclosporineDexamethasoneFetal BloodGranulocyte-Macrophage Colony-Stimulating FactorHumansInterleukin-10Macrophage Inflammatory ProteinsMast CellsProtein Kinase CPseudomonas aeruginosaReceptors, CCR6CCL20 protein, humanCCR6 protein, humanChemokine CCL20Chemokines, CCCyclosporineDexamethasoneGranulocyte-Macrophage Colony-Stimulating FactorInterleukin-10Macrophage Inflammatory ProteinsProtein Kinase CReceptors, CCR6Receptors, Chemokine

Identifiers

PMID12496186
PMCPMC143158
OpenAlexW2079753443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.